Cleared Abbreviated

RADSPA (K141329) - FDA 510(k) Clearance

Class II Radiology device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

K141329 · Telerad Tech Private Limited · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2014
Decision
30d
Days
Class 2
Risk

K141329 is an FDA 510(k) clearance for the RADSPA. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Telerad Tech Private Limited (Aurora, US). The FDA issued a Cleared decision on June 20, 2014 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Incremental AI imaging tool. Standards-verified equivalence. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Telerad Tech Private Limited devices

Submission Details

510(k) Number K141329 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 21, 2014
Decision Date June 20, 2014
Days to Decision 30 days
Submission Type Abbreviated
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
77d faster than avg
Panel avg: 107d · This submission: 30d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 730
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K141329.
eSie Apps Suite
K143254 · Siemens Medical Solutions USA, Inc. · Dec 2014
SYNGO.MR NEUROLOGY, SYNGO.MMR GENERAL
K140897 · Siemens Medical Solutions USA, Inc. · Jul 2014
ESIE APPS SUITE
K141554 · Siemens Medical Solutions USA, Inc. · Jul 2014
SYNO MR NEUROLOGY, SYNGO MR ONCOLOGY, SYNGO. MR BREVIS, SYNGO MMR GENERAL
K133401 · Siemens Medical Solutions USA, Inc. · Mar 2014
SCENIUM
K133654 · Siemens Medical Solutions USA, Inc. · Feb 2014
SYNGO.VIA MI WORKFLOWS
K133644 · Siemens Medical Solutions USA, Inc. · Feb 2014